Less Ads, More Data, More Tools Register for FREE

Pin to quick picksColefax Grp. Regulatory News (CFX)

Share Price Information for Colefax Grp. (CFX)

Share Price is delayed by 15 minutes
Get Live Data
1,420.00    25.00 (1.79%)
Bid:
1,400.00
Ask:
1,440.00
Spread: 40.00 (2.857%)
Market Cap: £73.35m
CFX Live PriceLast checked at - London Stock Exchange

Intraday Colefax Grp. Share Chart

Director/PDMR Shareholding

2 May 2006 17:00

Colefax Group PLC02 May 2006 Colefax Group PLC Grant of ESOP Options The Company today announces that options have been granted for nil considerationpursuant to agreements made between Mourant ECS Trustees (Jersey) Limited of 22Grenville Street, St Helier, Jersey JE4 8PX, as trustees of the Colefax GroupPlc Employees' Share Ownership Plan Trust (the "Trustees") and the Directorsnamed below: Director Number of Ordinary 10p Shares of the Company to which each option relates David Green 100,000Key Hall 100,000Rob Barker 75,000 The options were granted by the Trustees on 28th April 2006 and the aggregateexercise price per option payable by each person is £1 in total. The options areexercisable immediately but the shares may not be sold within three years of thegrant date. The options expire on 27th April 2016. The ESOP shares were acquiredby the Colefax Group Plc Employees Share Ownership Plan Trust between October1995 and September 2000 at an average cost of 65 pence per share. In addition to the above options Key Hall has outstanding options as follows: Quantity Exercise Price Date of Grant Expiry Date ESOP options 15,000 £1 total 14.11.01 23.07.07 Executive Share 20,000 111p 24.07.97 23.07.07 Option Scheme 100,000 83p 06.04.99 05.04.09 END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSResult of Share Buyback and TVR
28th May 20267:00 amRNSShare Buyback Launch
8th May 20267:00 amRNSFull Year Trading Update
10th Feb 20261:37 pmRNSTR-1 Notification
28th Jan 20267:00 amRNSHalf Year Results
30th Oct 20253:52 pmRNSTR-1 Notification
30th Oct 20253:38 pmRNSTR-1 Notification
30th Oct 20253:25 pmRNSTR-1 Notification
29th Oct 20251:59 pmRNSTR-1 Notification
28th Oct 20257:01 amRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSResult of Tender Offer, Purchase of Own Shares,TVR
13th Oct 20257:00 amRNSTender Offer
8th Oct 20251:03 pmRNSHolding(s) in Company
22nd Sep 20252:17 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
9th Sep 20252:28 pmRNSNotification of Transactions of Director
29th Jul 20257:00 amRNSPreliminary Results
3rd Feb 202512:48 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSHalf-year Results
27th Nov 20247:00 amRNSBoard Appointment
25th Oct 202412:16 pmRNSHolding(s) in Company
25th Oct 202411:18 amRNSDirector/PDMR Share Dealings
25th Oct 202411:08 amRNSHolding(s) in Company
24th Oct 20247:00 amRNSResult of Share Buyback
22nd Oct 20247:00 amRNSLaunch of Share Buyback Programme
26th Sep 20243:06 pmRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement
31st Jul 20247:00 amRNSPreliminary Results
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSInterim Results
2nd Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20232:59 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM Statement
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSResult of Tender Offer
1st Sep 20237:00 amRNSTender Offer
23rd Jan 20237:00 amRNSInterim Results
20th Dec 20223:27 pmRNSHolding(s) in Company
19th Oct 20225:21 pmRNSDirector/PDMR Shareholding
5th Oct 20224:55 pmRNSHolding(s) in Company
29th Sep 20223:22 pmRNSResult of AGM
29th Sep 20222:46 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSAGM Statement
26th Sep 20223:54 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
17th Aug 20227:00 amRNSPreliminary Results
21st Apr 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.